SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-021596
Filing Date
2024-04-24
Accepted
2024-04-24 08:00:35
Documents
8
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20019030x1_def14a.htm DEF 14A 908101
2 logo_pmvpharma.jpg GRAPHIC 55635
3 ny20019030x1_pc01.jpg GRAPHIC 602123
4 ny20019030x1_pc02.jpg GRAPHIC 465271
5 ny20019030x1_pvp01.jpg GRAPHIC 127491
6 ny20019030x1_pvp02.jpg GRAPHIC 114579
7 sig_davidhmack.jpg GRAPHIC 15618
8 sig_robertticktin.jpg GRAPHIC 17857
  Complete submission text file 0001140361-24-021596.txt   2833775
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39539 | Film No.: 24866759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)